1-7 of 7
Osnat Bohana-Kashtan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CXCR4 Inhibition with BL-8040 in Combination with Nelarabine in Patients with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia / Lymphoblastic Lymphoma

Geoffrey L. Uy, MD, Tapan M. Kadia, MD, Wendy Stock, MD, Jonathan E Brammer, MD, Osnat Bohana-Kashtan, PhD, Abi Vainstein, Ella Sorani, PhD, Hemda Chen, PharmD, John F. DiPersio, MD PhD, Daniel C. Link, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2630.
https://doi.org/10.1182/blood-2019-127121
Published: 2019
Journal Articles

CXCR4 Blockade By BL-8040 in T Cell Acute Lymphoblastic Leukemia Decreases Mitochondrial Mass and Induces Non-Apoptotic Cell Death

Jun Xia, PhD, Stephanie Sun, Matthew RM Jotte, Geoffrey L. Uy, MD, Osnat Bohana-Kashtan, PhD, Ella Sorani, PhD, Abi Vainstein, Amnon Peled, PhD, Daniel C. Link, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2745.
https://doi.org/10.1182/blood-2019-128881
Published: 2019
Journal Articles

The CXCR4 Antagonist, BL8040, Is Highly Active Against Human T-ALL in Preclinical Models

Jun Xia, PhD, Matthew RM Jotte, Stephanie Sun, Geoffrey L. Uy, MD, Abi Vainstein, Ella Sorani, PhD, Osnat Bohana-Kashtan, PhD, Stephen Shaw, PhD, Daniel C. Link, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2700.
https://doi.org/10.1182/blood-2018-99-117213
Published: 2018
Journal Articles

Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Transplantation and Phenotypic Characterization of the Leukapheresis Product

Michael P. Rettig, PhD, Geoffrey L. Uy, MD, Asad Bashey, MD PhD, Steven Devine, Samantha Jaglowski, MDMPH, Abi Vainstein, MD, Ella Sorani, PhD, Hemda Chen, PharmD, Osnat Bohana-Kashtan, PhD, Stephen Shaw, PhD, Peter Westervelt, MDPhD, John F. DiPersio, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 118.
https://doi.org/10.1182/blood-2018-99-109701
Published: 2018
Journal Articles

The YAP Transcriptional Co-Activator Is Not Required for Mouse Hematopoiesis, at Steady State or After 5FU Treatment.

Wen-Chih Cheng, PhD, Osnat Bohana-Kashtan, Sebastien Morisot, PhD, Nailing Zhang, Qian Chen, Duojia Pan, Curt I. Civin, MD
Journal: Blood
Blood (2010) 116 (21): 1592.
https://doi.org/10.1182/blood.V116.21.1592.1592
Published: 2010
Journal Articles

Leukemia Stem Cells (LSCs) Are Frequent in Childhood Precursor B Acute Lymphoblastic Leukemia (ALL).

Sebastien Morisot, MS, Alan S Wayne, MD, Osnat Bohana-Kashtan, PhD, Ian M Kaplan, BS, Richard Hildreth, MS, Patrick Brown, MD, Maryalice Stetler-Stevenson, MD, PhD, Curt I Civin, MD
Journal: Blood
Blood (2008) 112 (11): 1354.
https://doi.org/10.1182/blood.V112.11.1354.1354
Published: 2008
Journal Articles

Identification of New Alloantigen-Reactive CD8 + Cytotoxic and Suppressor T Cell Subpopulations.

Osnat Bohana-Kashtan, PhD, Hyam Levitsky, MD, Curt I. Civin, MD
Journal: Blood
Blood (2007) 110 (11): 3229.
https://doi.org/10.1182/blood.V110.11.3229.3229
Published: 2007